Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene
about
Effects of disruption of heat shock genes on susceptibility of Escherichia coli to fluoroquinolonesCloning, expression, and enzymatic characterization of Pseudomonas aeruginosa topoisomerase IVInsights into the environmental resistance gene pool from the genome sequence of the multidrug-resistant environmental isolate Escherichia coli SMS-3-5.Cloning and nucleotide sequences of the topoisomerase IV parC and parE genes of Mycoplasma hominis.Antibacterial activities and inhibitory effects of sitafloxacin (DU-6859a) and its optical isomers against type II topoisomerases.Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.Comparative in vitro activities of ciprofloxacin, clinafloxacin, gatifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Klebsiella pneumoniae, Klebsiella oxytoca, Enterobacter cloacae, and Enterobacter aerogenes clinical isolates with aIneffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.Alteration of Escherichia coli topoisomerase IV to novobiocin resistance.Molecular evaluation of antibiotic susceptibility: Tropheryma whipplei paradigmComparative genomics of 28 Salmonella enterica isolates: evidence for CRISPR-mediated adaptive sublineage evolution.A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics.Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV.Improved antimicrobial activity of DU-6859a, a new fluoroquinolone, against quinolone-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates with alterations in GyrA and ParC proteinsTopoisomerase IV, not gyrase, decatenates products of site-specific recombination in Escherichia coli.Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections.Emergence of fluoroquinolone-resistant Haemophilus influenzae strains among elderly patients but not among children.Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.Contribution of topoisomerase IV mutation to quinolone resistance in Mycoplasma genitalium.Quinolone-mediated bacterial death.Characterization of multiple-antimicrobial-resistant Escherichia coli isolates from diseased chickens and swine in China.Sequencing of gyrase and topoisomerase IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained In vitro.Mutation Supply and Relative Fitness Shape the Genotypes of Ciprofloxacin-Resistant Escherichia coliMolecular cloning of the gyrA and gyrB genes of Bacteroides fragilis encoding DNA gyrase.Activities of fluoroquinolones against Streptococcus pneumoniae type II topoisomerases purified as recombinant proteinsHigh-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA.Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of DNA topoisomerase IV associated with quinolone resistance in Enterococcus faecalis.Antibacterial activity of gatifloxacin (AM-1155, CG5501, BMS-206584), a newly developed fluoroquinolone, against sequentially acquired quinolone-resistant mutants and the norA transformant of Staphylococcus aureus.Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian type II topoisomerases.Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV of Enterococcus faecalis.Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility.Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae.Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones.Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae.In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections.Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong.Novel combination of mutations in the DNA gyrase and topoisomerase IV genes in laboratory-grown fluoroquinolone-resistant Shigella flexneri mutants.High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium.
P2860
Q24795620-647BDDD6-BC3A-4BB4-B231-AE588A4F15E2Q28492734-F4A445A3-60DA-4879-B805-96CF8963D3BEQ33360684-4D8CCA21-77AD-4A11-994B-1115C091187AQ33694924-2A20757C-9D03-4204-868C-18EEA2C29CA1Q33696363-E303DB2A-A415-44DA-AAC8-95773E51043AQ33976675-E04DF43A-1748-4BB7-B1D7-1B3355C04EDEQ33977480-342F3C38-A08A-4C5E-86C0-6BB8FAC5E77EQ33978398-D30AFB45-33DF-4C79-93CA-6F2298CBEE2FQ33982113-294D5968-D0E3-4318-B8CB-BD654C576D81Q34735901-DAF52B50-D0D8-4472-A3DE-BF8315F9EFA1Q34940257-954F6AD4-FEBA-422D-ABD8-59D366CFE873Q35096509-C22B865B-BCEF-42F5-9381-920ED513E88AQ35131092-0940AA43-954D-4635-88B3-A9C8DBE3B36CQ35131579-6AF0EE45-EC30-42EE-B6B2-1D7B90F44E69Q35139054-BB667425-8A2E-4077-A479-75CB4126A8B1Q35192431-9CEDD1FA-9A50-49ED-9E93-54E51B76EB33Q36048167-6EBA4E15-DD75-4AE5-9E7E-7901BA7C04F2Q36423756-BAE160D6-D0C9-47E1-AAE9-3E7577CD3A74Q36546371-42E7A7BE-F297-4ADD-B06A-631FCFFD2EFAQ36757682-CAC87D2E-50A4-4A06-953C-8A14FE7C47FDQ36921143-F59D600F-6425-4772-9598-8C19EA45AC1CQ37157491-DAACE96B-9DB3-44A6-8C23-287F972A832EQ37880162-9824DE11-83C5-4D9C-B143-CC4119FD7E2DQ39020968-38E0DDC3-F52F-48D0-8291-6C365C72928FQ39471928-283DF9C0-3D97-4891-80F0-54084BB466ECQ39472105-221949A4-CA58-428B-BEAC-895358B9AF83Q39475770-41CDC09F-C244-4A9C-8A00-9B3E00CE35BAQ39556784-E5466945-DF18-4431-92A3-6A15B533077AQ39558211-A7B8EA9C-1CEB-4D1A-98FA-4D83FFCE9D7CQ39559188-55B005B2-A836-4412-8908-C69AD09A8A84Q39651895-05AD904F-21BD-426C-8AE3-2D60BC3DB99BQ39652979-2780BB0E-C814-43BF-80AE-4FE86CB20341Q39782937-9C36BAFE-9F24-4875-B751-948E536FBFEFQ39783715-82D6009D-7F34-408E-A661-620F5294BAF3Q39783862-2FDCC5C1-9079-4711-B905-9D405C26F47CQ39784609-FF31737F-A514-4A88-9699-A9E985909EF1Q40130546-7B842B73-F221-49A5-A034-1CEA36C77B55Q42743898-D3DAA4BA-ADEA-4DAE-961C-8A060BE728DBQ43234730-7CC7BC76-1A2D-4CAE-BF74-77834E7AE9E1
P2860
Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene
@en
Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.
@nl
type
label
Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene
@en
Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.
@nl
prefLabel
Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene
@en
Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.
@nl
P2093
P2860
P1476
Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene
@en
P2093
P2860
P304
P407
P577
1996-03-01T00:00:00Z